Age is a major risk factor for both muscle loss and cognitive decline. According to the World Health Organization, 55 million people worldwide have dementia, with cases expected to double every five years as the global population ages.

Brain changes with age are subtle but significant. Contrary to popular belief, we lose less than 10% of neurons in the central nervous system, primarily in specific regions. However, there is a reduction in axons, synapses, dendrites, and dendritic spines, which are crucial for neuron communication and information transmission.

Links between muscle mass loss and cognitive decline include changes in muscle-specific chemicals (myokines), inflammation, insulin dysregulation, protein accumulation issues, oxidative stress, and mitochondrial dysfunction. 

Neuroinflammation, an inflammatory response in the brain, is a key player. Increased production of inflammatory chemicals with age can breach the blood-brain barrier, contributing to conditions like Alzheimer’s disease. The protein Aβ in Alzheimer’s patients activates microglia, brain immune cells, leading to increased inflammation.

Insulin dysregulation also affects brain health. Insulin, crucial for brain function, decreases with age, disrupting brain insulin dynamics and contributing to neurodegenerative diseases by increasing harmful proteins like tau, altering brain plasticity, and heightening inflammation  

The mTOR pathway, essential for protein synthesis and cellular function, becomes disturbed with age, affecting mitochondria and contributing to cognitive decline. Mitochondrial damage accumulates due to ROS, creating a feedback loop that impairs energy production and exacerbates cellular damage.

Understanding these mechanisms is crucial for addressing cognitive decline associated with aging muscles.

Learn More: www.drinkbc6.com